What are the recommended deworming regimens and dosing for school‑age children, preschool children, and at‑risk adults in endemic areas, including albendazole, mebendazole, ivermectin, praziquantel, and pregnancy considerations?

Deworming Guidelines for Endemic Areas

For school-age children and preschool children over 24 months in endemic areas, administer albendazole 400 mg or mebendazole 500 mg as a single dose every 6 months; for high-risk adults, use the same regimen, with specific modifications based on parasite species and infection intensity. 1, 2

Core Dosing Regimens by Population

School-Age Children and Preschool Children (>24 months)

Standard preventive chemotherapy:

• Albendazole 400 mg PO single dose OR Mebendazole 500 mg PO single dose 1
• Administer every 6 months in endemic areas 1
• For children 12-24 months, seek expert consultation before treatment 1

Alternative regimen:

• Ivermectin 200 μg/kg PO single dose can be used for soil-transmitted helminths 1
• Critical caveat: Exclude Loa loa infection before giving ivermectin in travelers from endemic regions (Central/West Africa) to prevent severe adverse reactions 1

At-Risk Adults

Use identical dosing to children:

• Albendazole 400 mg PO single dose OR Mebendazole 500 mg PO single dose 1
• Repeat every 6 months in high-transmission settings 1

Species-Specific Treatment Modifications

Ascariasis (Ascaris lumbricoides)

• Single dose: Albendazole 400 mg OR Mebendazole 500 mg OR Ivermectin 200 μg/kg 1
• All three options show equivalent high efficacy (>90% cure rate) 3, 4

Hookworm (Ancylostoma duodenale, Necator americanus)

• Albendazole 400 mg PO daily for 3 days (superior to single dose) 1
• Single-dose mebendazole shows lower efficacy against hookworm; multi-day regimens preferred 5, 4

Whipworm (Trichuris trichiura)

• Mebendazole 100 mg PO twice daily PLUS Ivermectin 200 μg/kg PO once daily for 3 days 1
• Combination therapy essential—single-dose regimens show poor cure rates (<50%) 5, 4
• Exclude Loa loa before ivermectin use 1

Threadworm/Pinworm (Enterobius vermicularis)

• Albendazole 400 mg PO single dose, repeat in 2 weeks 1
• Mebendazole 100 mg PO twice daily for 3 days (alternative) 6

Schistosomiasis

• S. mansoni, S. intercalatum, S. guineensis: Praziquantel 40 mg/kg PO single dose 1
• S. japonicum, S. mekongi: Praziquantel 60 mg/kg PO divided in 2 doses 1
• For empirical treatment when species unknown (Asia-Pacific region): use 60 mg/kg divided dose 1
• Repeat treatment at 8 weeks to target immature schistosomulae that survive initial therapy 1

Pregnancy Considerations

Contraindications and Warnings

Albendazole and mebendazole are contraindicated in the first trimester due to teratogenic risk demonstrated in animal studies 2, 7

Second and third trimester:

• Mebendazole is preferred over albendazole when treatment cannot be delayed 7
• One large study (5,275 women) showed mebendazole in second/third trimester was NOT associated with increased congenital defects and actually correlated with lower rates of stillbirth and low birthweight 7
• Avoid albendazole if possible; if used, obtain pregnancy test first and ensure effective contraception during treatment and for 3 days after 2

Praziquantel:

• Very low excretion into breastmilk, likely compatible with breastfeeding 1
• Can be used when benefits outweigh risks

Ivermectin:

• Limited human pregnancy data; probably compatible but use cautiously 1

Severe Infections Requiring Treatment During Pregnancy

• Amphotericin B (lipid formulation 3-5 mg/kg daily OR deoxycholate 0.7-1 mg/kg daily) for life-threatening helminthic infections 8, 9
• Local hyperthermia can treat cutaneous infections without systemic drug exposure 8

Empirical Treatment for Asymptomatic Eosinophilia

When stool microscopy is negative but eosinophilia persists in travelers/migrants:

• Albendazole 400 mg PO single dose PLUS Ivermectin 200 μg/kg PO single dose 1
• Age >24 months only; discuss with expert for ages 12-24 months 1
• Mandatory: Exclude Loa loa before ivermectin in those with Central/West African exposure 1

Critical Safety Monitoring

Albendazole-Specific Warnings

• Monitor CBC at baseline and every 2 weeks during treatment—risk of bone marrow suppression, agranulocytosis, pancytopenia 2
• Monitor liver enzymes before each cycle and every 2 weeks—discontinue if transaminases exceed 2× upper limit of normal 2
• Fatalities reported from granulocytopenia/pancytopenia 2

Drug Administration Tips

• Take with food to enhance absorption (especially albendazole) 2
• Tablets can be crushed or chewed 6, 2
• No fasting or purging required 6

Common Pitfalls to Avoid

1. Single-dose failure for hookworm: Albendazole requires 3-day course for adequate hookworm cure rates 1

2. Whipworm monotherapy: Single-dose albendazole or mebendazole shows <50% cure rate; combination with ivermectin essential 1, 5, 4

3. Ivermectin in Loa loa co-endemic areas: Can cause fatal encephalopathy if microfilaremia >8,000 mf/mL; always exclude before treatment 1, 10

4. First trimester exposure: Albendazole and mebendazole are teratogenic; pregnancy testing mandatory for women of reproductive age 2

5. Assuming single-dose efficacy: Recent studies show diminishing returns—one Dominican Republic study found <50% clearance of Ascaris at 2-4 weeks post-albendazole, with reinfection rates returning to baseline by 12-16 weeks 11

6. Schistosomiasis timing: Immature parasites resist treatment; repeat dosing at 8 weeks captures matured worms 1

Pediatric Dosing Adjustments

For children requiring weight-based dosing:

• Albendazole: 15 mg/kg/day divided twice daily (maximum 800 mg/day) for hydatid/neurocysticercosis 2
• Mebendazole: Standard adult doses well-tolerated in children 6
• Ivermectin: 200 μg/kg (same as adults) 1
• Praziquantel: 25 mg/kg for Hymenolepis; 40-60 mg/kg for schistosomiasis depending on species 1